See more : Advance Petrochemicals Limited (ADVPETR-B.BO) Income Statement Analysis – Financial Results
Complete financial analysis of PayChest, Inc. (PYCT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PayChest, Inc., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Rentokil Initial plc (RKLIF) Income Statement Analysis – Financial Results
- Atlas Energy Solutions Inc. (AESI) Income Statement Analysis – Financial Results
- Goldhills Holding Ltd. (GODZF) Income Statement Analysis – Financial Results
- Resource Development Group Limited (RDG.AX) Income Statement Analysis – Financial Results
- Contagious Gaming Inc. (KSMRF) Income Statement Analysis – Financial Results
PayChest, Inc. (PYCT)
About PayChest, Inc.
Paychest, Inc., a marketing company, licenses non-polluting technologies for the development and commercialization. It offers a range of feminine hygiene products under the Mibella brand name using Flushaway technology, which are flushable, biodegradable, and dispersible. The company also engages in developing Mibella and Flushaway technology solutions to deliver biodegradable diapers for babies, as well as a product for adult incontinence protection. In addition, it offers winged pads and pantiliners. The company offers its products through retailers in the United States, Hong Kong, South Africa, Australia, and the United Kingdom. The company was formerly known as Mellon Research, Inc. and changed its name to Paychest, Inc. in January 2006. Paychest, Inc. was founded in 2000 and is based in Blaine, Washington.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 96.77K | 163.39K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 96.77K | 163.39K |
Cost & Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 96.77K | 163.39K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 228.49K | 236.56K | 206.30K | 171.86K | 161.14K | 52.52K | 22.82K | 0.00 |
EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -96.77K | -2.35M |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -96.77K | -163.39K |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | -2.19M |
Income Before Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -96.77K | -2.35M |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -22.82K | 0.00 |
Net Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -96.77K | -2.35M |
Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 27.69B | 27.69B |
Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 27.69B | 27.69B |
Source: https://incomestatements.info
Category: Stock Reports